Rafa Laboratories

U.S. Taps Israel’s Rafa to Advance Prehospital Lifesaving Bleeding Treatment

U.S. taps Israel’s Rafa to advance prehospital lifesaving bleeding treatment with new $186 million contract for intramuscular TXA formulation.